As of 2026-05-29, the Fair Value of Fusion Antibodies PLC (FAB.L) is -5.34 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 13.00 GBP, the upside of Fusion Antibodies PLC is -141.10%.
With the market price of 13.00 GBP and our fair value calculation, Fusion Antibodies PLC (FAB.L) is not a good investment. Investing in FAB.L stocks now will result in a potential loss of 141.10%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 5Y Avg | |
| Net income | -2.90 | -1.20 | -2.60 | -2.23 | -1.71 | -2.13 |
| YoY growth | -315.93% | 58.61% | -116.33% | 14.25% | 23.05% | -67.27% |
| Market Cap (mil) | 17.85 |
| P/E | |
| Forward P/E |
| EPS | -1.07 |
| Avg earnings growth rate | -67.27% |
| TTM earnings | -1.47 |